Accumulation of γ-globin mRNA in human erythroid cells treated with angelicin

European Journal of Haematology

Volumn 71, Issue 3, 2003, Pages 189-198

  Lampronti, Ilaria ^a   Bianchi, Nicoletta ^a   Borgatti, Monica ^a   Fibach, Eitan ^b   Prus, Eugenia ^b   Gambari, Roberto ^a,c  

^a UNIVERSITY OF FERRARA   (Italy)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Angelicin; Erythroid differentiation; Fetal hemoglobin; Sickle cell anemia; thalassemia; globin

Indexed keywords

ANGELICIN; CISPLATIN; CYTARABINE; GAMMA GLOBIN; MESSENGER RNA; MITHRAMYCIN;

ARTICLE; BETA THALASSEMIA; CELL STRAIN K 562; DRUG EFFECT; DRUG STRUCTURE; ERYTHROID CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LIQUID CULTURE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STEM CELL;

EID: 0042835383     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00113.x     Document Type: Article

References (36)

1. RODGERS GP, RACHMILEWITZ EA. Novel treatment options in the severe β-globin disorder. Br J Haematol 1995;91:263-268.
2. ROCHETTE J, CRAIG JE, THEIN SL. Fetal hemoglobin levels in adults. Blood Rev 1994;8:213-224.
3. OLIVIERI NF, REES, DC, GINDER DG, THEIN SL, WAYE JS, CHANG L, BRITTENHAM GM, WEATHERALL DJ. Elimination of transfusion through induction of fetal hemoglobin synthesis in Cooley's anemia. Ann NY Acad Sci USA 1998;850:100-109.
4. SWANK RA, STAMATOYANNOPOULOS G. Fetal gene reactivation. Curr Opin Genet Dev 1998;8:366-370.
5. STEINBERG MH, LU ZH, BARTON FB, TERRIN ML, CHARACHE S, DOVER GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 1997;89:1078-1088.
6. FIBACH E, PRASANNA P, RODGERS GP, SAMID D. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and β-thalassemia. Blood 1993;82:2203-2209.
7. RODGERS GP, DOVER GJ, UYESAKA N, NOGUCHI CT, SCHECHTER AN, NIENHUIS AW. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cells disease. N Engl J Med 1993;328:73-80.
8. PERRINE SP, GINDER GD, FALLER DV, DOVER GH, IKUTA T, WITKOWSKA HE, CAI SP, VICHINSKY EP, OLIVIERI NF. A short-term trial of butyrate to stimulate fetal-globin gene expression in the β-globin disorders. N Engl J Med 1993;328:81-86.
9. BIANCHI N, OSTI F, RUTIGLIANO C, GINANNI CORRADINI F, BORSETTI E, TOMASSETTI M, MISCHIATI C, FERIOTTO G, GAMBARI R. The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br J Haematol 1999;104:258-263.
10. BIANCHI N, CHIARABELLI C, BORGATTI M, MISCHIATI C, FIBACH E, GAMBARI R. Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukemia K562 cells with tallimustine. Br J Haematol 2001;113:951-961.
11. BIANCHI N, ONGARO F, CHIARABELLI C, GUALANDI L, MISCHIATI C, BERGAMINI P, GAMBARI R. Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem Pharmacol 2000;60:31-40.
12. CHILIN A, MARZANO C, GUIOTTO A, MANZINI P, BACCICHETTI F, CARLASSARE F, BORDIN F. Synthesis and biological activity of (hydroxymethyl)- and (diethylaminomethyl)-benzopsoralens. J Med Chem 1999;42:2936-2945.
13. BORDIN F, MARZANO C, BACCICHETTI F, CARLASSARE F, VEDALDI D, FALCOMER S, LORA S, RODIGHIERO P. Photobiological properties of 1′-thieno-4,6,4′ -trimethylangelicin. Photochem Photobiol 1998;68:157-163.
14. CONCONI MT, MONTESI F, PARNIGOTTO PP. Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-methoxyangelicin. Pharmacol Toxicol 1998;82:193-198.
15. MARZANO C, CAFFIERI S, FOSSA P, BORDIN F. Activity of 3-carbethoxyangelicin photolysis products. J Photochem Photobiol B 1997;38:189-195.
16. BORDIN F, DALL'ACQUA F, GUIOTTO A. Angelicins, angular analogs of psoralens: chemistry, photochemical, photobiological and phototherapeutic properties. Pharmacol Ther 1991;52:331-363.
17. GUIOTTO A, RODIGHIERO P, MANZINI P, et al. 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. J Med Chem 1984;27:959-967.
18. PARRISH JA. Phototherapy and photochemotherapy of skin diseases. J Invest Dermatol 1981;77:167-171.
19. SARDARI S, MORI Y, HORITA K, MICETICH RG, NISHIBE S, DANESHTALAB M. Synthesis and antifungal activity of coumarins and angular furanocoumarins. Bioorg Med Chem 1999;7:1933-1940.
20. KOMURA J, IKEHATA H, HOSOI Y, RIGGS AD, ONO T. Mapping psoralen cross-links at the nucleotide level in mammalian cells: suppression of cross-linking at transcription factor- or nucleosome-binding sites. Biochemistry 2001;40:4096-4105.
21. MOSTI L, LO PRESTI E, MENOZZI G, MARZANO C, BACCICHETTI F, FALCONE G, FILIPPELLI W, PIUCCI B. Synthesis of angelicin heteroanalogues: preliminary photobiological and pharmacological studies. Farmaco 1998;53:602-610.
22. RUTHERFORD TR, CLEGG JB, WEATHERALL DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 1979;280:164-165.
23. GAMBARI R, DEL SENNO L, BARBIERI R, VIOLA L, TRIPODI M, RASCHELLÀ G, FANTONI A. Human leukemia K-562 cells: induction of erythoid differentiation by 5-azacytidine. Cell Differ 1984;14:87-97.
24. FIBACH E, MANOR D, OPPENHEIM A, RACHMILEWITZ EA. Proliferation and maturation of human erythroid progenitors in liquid medium. Blood 1989;73:100-103.
25. POPE SH, FIBACH E, SUN J, CHIN K, RODGERS GP. Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level. Eur J Haematol 2000;64:292-303.
26. LOZZIO CB, LOZZIO BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia-chromosome. Blood 1975;45:321-334.
27. HUANG SZ, RODGERS GP, ZENG FY, ZENG YT, SCHECHTER AN. Diagnosis of Thalassemia using cDNA amplification of circulating erythroid cell mRNA with the polymerase-chain reaction. Blood 1991;78:2433-2437.
28. FIBACH E, RACHMILEWITZ EA. The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells 1993;11:36-41.
29. FIBACH E, BURKE LP, SCHECHTER AN, NOGUCHI CT, RODGERS GP. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia. Blood 1993;81;1630-1635.
30. AL-KHATTI A, PAPAYANNOPOULOU T, KNITTER G, FRITSCH EF, STAMATOYANNOPOULOS G. Cooperative enhancement of F-cell formation in baboons treated with erythropoietin and hydroxyurea. Blood 1988;72:817-819.
31. CHARACHE S, DOVER GJ, MOORE RD, et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992;79:2555-2565.
32. RODGERS GP, DOVER GJ, NOGUCHI CT, SCHECHTER AN, NIENHUIS AW. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 1990;322:1037-1045.
33. MIOLO G, MORO S, VEDALDI D, CAFFIERI S, GUIOTTO A, DALL'ACQUA F. New benzoquinolizin-5-one derivatives as furocoumarin analogs: DNA-interactions and molecular modeling studies. Farmaco 1999;54:551-561.
34. GIA O, URIARTE E, ZAGOTTO G, BACCICHETTI F, ANTONELLO C, MARCIANI-MAGNO S. Synthesis and photobiological activity of new methylpsoralen derivatives. J Photochem Photobiol B 1992;14:95-104.
35. LOWREY CH, NIENHUIS AW. Brief report: treatment with azacytidine of patients with end stage β-thalassemia. Engl J Med 1993;329:845-848.
36. SHER GD, GINDER GD, LITTLE J, YANG S, DOVER GJ, OLIVIERI NF. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies. N Engl J Med 1995;332:1606-1610.